Bos taurus Gene: PPP2R5D
InnateDB Gene IDBG-631343.3
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol PPP2R5D
Gene Name serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform
Species Bos taurus
Ensembl Gene ENSBTAG00000005533
Encoded Proteins
Uncharacterized protein
Protein Structure
Useful resources Stemformatics EHFPI ImmGen
Entrez Gene
Summary This gene does not have any Entrez summary - the following is the summary from its human ortholog ENSG00000112640:
The product of this gene belongs to the phosphatase 2A regulatory subunit B family. Protein phosphatase 2A is one of the four major Ser/Thr phosphatases, and it is implicated in the negative control of cell growth and division. It consists of a common heteromeric core enzyme, which is composed of a catalytic subunit and a constant regulatory subunit, that associates with a variety of regulatory subunits. The B regulatory subunit might modulate substrate selectivity and catalytic activity. This gene encodes a delta isoform of the regulatory subunit B56 subfamily. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Gene Information
Type Protein coding
Genomic Location Chromosome 23:16602190-16625464
Strand Forward strand
ENSBTAT00000007277 ENSBTAP00000007277
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 26 interaction(s) predicted by orthology.
Predicted by orthology
Total 26 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0005488 binding
GO:0005515 protein binding
GO:0008601 protein phosphatase type 2A regulator activity
Biological Process
GO:0007165 signal transduction
GO:0050790 regulation of catalytic activity
Cellular Component
GO:0000159 protein phosphatase type 2A complex
Homo sapiens
Mus musculus
Gene ID
Gene Order
Pathway Predictions based on Human Orthology Data
Resolution of Sister Chromatid Cohesion pathway
Mitotic Prometaphase pathway
Separation of Sister Chromatids pathway
ERKs are inactivated pathway
ERK/MAPK targets pathway
MyD88-independent cascade pathway
Toll Like Receptor 3 (TLR3) Cascade pathway
MyD88:Mal cascade initiated on plasma membrane pathway
Toll Like Receptor TLR1:TLR2 Cascade pathway
Toll Like Receptor TLR6:TLR2 Cascade pathway
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation pathway
MyD88 dependent cascade initiated on endosome pathway
Toll Like Receptor 9 (TLR9) Cascade pathway
MyD88 cascade initiated on plasma membrane pathway
Toll Like Receptor 10 (TLR10) Cascade pathway
Toll Like Receptor 4 (TLR4) Cascade pathway
Toll Like Receptor 5 (TLR5) Cascade pathway
CTLA4 inhibitory signaling pathway
Costimulation by the CD28 family pathway
Platelet sensitization by LDL pathway
Platelet homeostasis pathway
DARPP-32 events pathway
Opioid Signalling pathway
Beta-catenin phosphorylation cascade pathway
Degradation of beta-catenin by the destruction complex pathway
Glycolysis pathway
PP2A-mediated dephosphorylation of key metabolic factors pathway
Integration of energy metabolism pathway
truncated APC mutants destabilize the destruction complex pathway
Signalling by NGF pathway
AXIN mutants destabilize the destruction complex, activating WNT signaling pathway
Toll Like Receptor 7/8 (TLR7/8) Cascade pathway
APC truncation mutants are not K63 polyubiquitinated pathway
AMER1 mutants destabilize the destruction complex pathway
misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling pathway
Signaling by WNT in cancer pathway
Myoclonic epilepsy of Lafora pathway
AXIN missense mutants destabilize the destruction complex pathway
Signaling by Wnt pathway
Metabolism of carbohydrates pathway
Signaling by GPCR pathway
Innate Immune System pathway
disassembly of the destruction complex and recruitment of AXIN to the membrane pathway
APC truncation mutants have impaired AXIN binding pathway
Toll Like Receptor 2 (TLR2) Cascade pathway
Toll-Like Receptors Cascades pathway
T41 mutants of beta-catenin aren't phosphorylated pathway
Signal Transduction pathway
MAP kinase activation in TLR cascade pathway
misspliced GSK3beta mutants stabilize beta-catenin pathway
S45 mutants of beta-catenin aren't phosphorylated pathway
deletions in the AMER1 gene destabilize the destruction complex pathway
Cell Cycle pathway
Adaptive Immune System pathway
Immune System pathway
S33 mutants of beta-catenin aren't phosphorylated pathway
truncations of AMER1 destabilize the destruction complex pathway
M Phase pathway
Mitotic Anaphase pathway
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex pathway
TCF dependent signaling in response to WNT pathway
NGF signalling via TRKA from the plasma membrane pathway
deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling pathway
Cell Cycle, Mitotic pathway
RNF mutants show enhanced WNT signaling and proliferation pathway
TCF7L2 mutants don't bind CTBP pathway
Activated TLR4 signalling pathway
Nuclear Events (kinase and transcription factor activation) pathway
Metabolism pathway
MAPK targets/ Nuclear events mediated by MAP kinases pathway
XAV939 inhibits tankyrase, stabilizing AXIN pathway
TRIF-mediated TLR3/TLR4 signaling pathway
S37 mutants of beta-catenin aren't phosphorylated pathway
Disease pathway
Glucose metabolism pathway
Glycogen storage diseases pathway
Hemostasis pathway
Mitotic Metaphase and Anaphase pathway
Oocyte meiosis pathway
mRNA surveillance pathway pathway
Oocyte meiosis pathway
mRNA surveillance pathway pathway
Insulin receptor signaling pathway
GPCR Dopamine D1like receptor signaling pathway pathway
Alpha-synuclein signaling
Aurora A signaling
Presenilin action in Notch and Wnt signaling
Aurora B signaling
Lissencephaly gene (LIS1) in neuronal migration and development
UniProt Splice Variant
Entrez Gene
UniGene Bt.64650
RefSeq NM_001206358 XM_005223370 XM_005223371
RNA Seq Atlas